1. Home
  2. PCTY vs QGEN Comparison

PCTY vs QGEN Comparison

Compare PCTY & QGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Paylocity Holding Corporation

PCTY

Paylocity Holding Corporation

HOLD

Current Price

$146.23

Market Cap

7.8B

Sector

Technology

ML Signal

HOLD

QGEN

Qiagen N.V.

HOLD

Current Price

$45.50

Market Cap

9.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PCTY
QGEN
Founded
1997
1986
Country
United States
Netherlands
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
7.8B
9.0B
IPO Year
2014
1998

Fundamental Metrics

Financial Performance
Metric
PCTY
QGEN
Price
$146.23
$45.50
Analyst Decision
Strong Buy
Buy
Analyst Count
21
16
Target Price
★ $172.15
$46.27
AVG Volume (30 Days)
564.6K
★ 1.8M
Earning Date
11-03-2026
11-03-2026
Dividend Yield
N/A
★ 6.03%
EPS Growth
★ 22.39
N/A
EPS
★ 4.92
N/A
Revenue
★ $1,771,326,000.00
N/A
Revenue This Year
$6.90
$2.19
Revenue Next Year
$7.83
$5.06
P/E Ratio
$29.93
★ $24.01
Revenue Growth
★ 11.04
N/A
52 Week Low
$92.99
$32.53
52 Week High
$161.93
$57.82

Technical Indicators

Market Signals
Indicator
PCTY
QGEN
Relative Strength Index (RSI) 51.99 57.74
Support Level $140.01 $45.39
Resistance Level $148.70 $49.40
Average True Range (ATR) 3.82 1.12
MACD 0.04 0.10
Stochastic Oscillator 74.36 67.23

Price Performance

Historical Comparison
PCTY
QGEN

About PCTY Paylocity Holding Corporation

Paylocity is a cloud-based human capital management provider offering payroll, compliance, and human resources management solutions. With the addition of expense and IT management modules, Paylocity unifies back-office operations spanning HR, finance, and IT on a single platform and bills customers on a subscription basis. The firm's customer base skews toward the midmarket and is primarily based in the US. As of fiscal 2026, Paylocity has nearly 44,400 customers.

About QGEN Qiagen N.V.

Qiagen offers proprietary sample and assay technology to extract, purify, amplify, and interpret DNA, RNA, and proteins. The company's sales are split almost evenly between applications in life sciences and molecular diagnostics. Qiagen generates nearly 90% of its revenue from consumables, with the balance coming from instrumentation and related services. The Americas account for the largest portion of the firm's revenue (52% of 2024 sales), followed by Europe, the Middle East, and Africa (33%) and Asia-Pacific (15%).

Share on Social Networks: